David Johnson
Gastroenterology · Norfolk, VANPI 1447236112
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $49,674 of the $58,038 with a category attached, or 85.6%. 23 manufacturers reported payments, led by Boehringer Ingelheim International GmbH at 53.0% of the total. Reporting peaked in 2022 at $19,961 and has fallen 99.4% since, to $114 in 2025. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $417.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$31K
- Aries Pharmaceuticals, Inc.$14K
- Hikma Pharmaceuticals USA$5K
- Global Blood Therapeutics, Inc.$3K
- Ironwood Pharmaceuticals, Inc$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- plus $2K from 17 others
Across 9 payments — averaging $2281.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Covidien LP$5K
- Medtronic$5K
- Ironwood Pharmaceuticals, Inc$4K
- Shionogi Inc$4K
- Boehringer Ingelheim International GmbH$2K
- Janssen Research & Development, LLC$1K
What the payments were for
- Consulting fees$49,67486%
- Speaking & faculty fees$6,40011%
- Food & beverage$1,9643%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 9 | $30,780 |
| Aries Pharmaceuticals, Inc. | 4 | $13,518 |
| Hikma Pharmaceuticals USA | 1 | $5,000 |
| Global Blood Therapeutics, Inc. | 1 | $3,328 |
| Ironwood Pharmaceuticals, Inc | 1 | $2,048 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $1,829 |
| AbbVie | 48 | $825 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $138 |
| Johnson & Johnson | 14 | $135 |
| Gilead | 7 | $109 |
| Intercept Pharmaceuticals, Inc. | 5 | $74 |
| Braintree Laboratories, Inc. | 3 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $23 |
| Merck | 1 | $22 |
| Dova Pharmaceuticals | 1 | $22 |
| UCB, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$58,038 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.
Other gastroenterology in Norfolk
- Michael RyanNorfolk$335K
- Edward OldfieldNorfolk$26K
- Alan GamseyNorfolk$14K
- Larry ClarkLynchburg$1.2M
- Arun SanyalRichmond$855K
- Mitchell ShiffmanNewport News$635K
- Bryan SauerCharlottesville$540K
- Brian WentworthCharlottesville$276K
- Vanessa ShamiCharlottesville$210K
- Ali SiddiquiFairfax$167K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.